US Stock MarketDetailed Quotes

RLAY Relay Therapeutics

Watchlist
  • 6.740
  • -0.320-4.53%
Close May 7 16:00 ET
  • 6.750
  • +0.010+0.15%
Post 18:59 ET
894.68MMarket Cap-2562P/E (TTM)

Relay Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
4,327.88%10.01M
1,749.82%25.55M
-100.40%-1K
7,226.16%25.2M
-67.40%119K
-46.06%226K
-54.41%1.38M
-55.38%253K
-48.35%344K
-56.75%365K
Operating revenue
4,327.88%10.01M
1,749.82%25.55M
-100.40%-1K
7,226.16%25.2M
-67.40%119K
-46.06%226K
-54.41%1.38M
-55.38%253K
-48.35%344K
-56.75%365K
Cost of revenue
Gross profit
Operating expense
-0.20%102.2M
29.66%404.97M
12.69%94.26M
20.49%99.98M
38.92%108.32M
51.19%102.41M
35.78%312.33M
24.01%83.65M
39.09%82.97M
30.90%77.98M
Selling and administrative expenses
1.12%19.8M
13.60%74.95M
2.41%16.77M
15.00%18.49M
15.20%20.12M
21.85%19.58M
14.97%65.98M
5.30%16.37M
9.48%16.07M
21.10%17.47M
-General and administrative expense
1.12%19.8M
13.60%74.95M
2.41%16.77M
15.00%18.49M
15.20%20.12M
21.85%19.58M
14.97%65.98M
5.30%16.37M
9.48%16.07M
21.10%17.47M
Research and development costs
-0.51%82.4M
33.96%330.02M
15.19%77.5M
21.81%81.49M
45.76%88.2M
60.31%82.83M
42.69%246.36M
29.61%67.28M
48.75%66.9M
34.03%60.51M
Operating profit
9.77%-92.2M
-22.02%-379.42M
-13.03%-94.26M
9.50%-74.78M
-39.42%-108.2M
-51.79%-102.18M
-36.98%-310.95M
-24.68%-83.4M
-40.07%-82.63M
-32.16%-77.61M
Net non-operating interest income expense
28.96%8.95M
253.35%31.05M
61.95%8.7M
357.97%7.85M
652.14%7.56M
897.27%6.94M
958.55%8.79M
1,911.99%5.37M
991.08%1.71M
458.33%1.01M
Non-operating interest income
28.96%8.95M
253.35%31.05M
61.95%8.7M
357.97%7.85M
652.14%7.56M
897.27%6.94M
958.55%8.79M
1,911.99%5.37M
991.08%1.71M
458.33%1.01M
Other net income (expense)
85.70%1.86M
-45.06%6.4M
-80.34%2.07M
136.80%1.2M
1,274.73%2.14M
-78.14%1M
108.47%11.66M
1,358.37%10.52M
-62.75%-3.26M
99.87%-182K
Special income (charges)
82.65%1.83M
-45.00%6.42M
-80.40%2.07M
136.79%1.2M
1,176.00%2.15M
-78.17%1M
108.48%11.68M
1,361.24%10.54M
-63.10%-3.26M
99.85%-200K
-Less：Restructuring and merger&acquisition
-82.65%-1.83M
45.00%-6.42M
80.40%-2.07M
-136.79%-1.2M
-1,176.00%-2.15M
78.17%-1M
-179.48%-11.68M
-1,361.24%-10.54M
63.10%3.26M
-98.31%200K
Other non- operating income (expenses)
933.33%25K
10.00%-18K
104.17%1K
-128.57%-2K
-177.78%-14K
85.71%-3K
-400.00%-20K
---24K
--7K
1,700.00%18K
Income before tax
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
-38.37%-84.17M
60.30%-76.79M
Income tax
Net income
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
-38.37%-84.17M
60.30%-76.79M
Net income continuous Operations
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
-38.37%-84.17M
60.30%-76.79M
Minority interest income
Net income attributable to the parent company
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
-38.37%-84.17M
60.30%-76.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
21.91%-65.73M
-28.28%-98.51M
-51.89%-94.24M
20.16%-290.51M
-0.07%-67.5M
-38.37%-84.17M
60.30%-76.79M
Basic earnings per share
20.51%-0.62
-7.72%-2.79
-19.64%-0.67
28.95%-0.54
-14.08%-0.81
-36.84%-0.78
32.20%-2.59
9.68%-0.56
-15.15%-0.76
66.19%-0.71
Diluted earnings per share
20.51%-0.62
-7.72%-2.79
-19.64%-0.67
28.95%-0.54
-14.08%-0.81
-36.84%-0.78
32.20%-2.59
9.68%-0.56
-15.15%-0.76
66.19%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 4,327.88%10.01M1,749.82%25.55M-100.40%-1K7,226.16%25.2M-67.40%119K-46.06%226K-54.41%1.38M-55.38%253K-48.35%344K-56.75%365K
Operating revenue 4,327.88%10.01M1,749.82%25.55M-100.40%-1K7,226.16%25.2M-67.40%119K-46.06%226K-54.41%1.38M-55.38%253K-48.35%344K-56.75%365K
Cost of revenue
Gross profit
Operating expense -0.20%102.2M29.66%404.97M12.69%94.26M20.49%99.98M38.92%108.32M51.19%102.41M35.78%312.33M24.01%83.65M39.09%82.97M30.90%77.98M
Selling and administrative expenses 1.12%19.8M13.60%74.95M2.41%16.77M15.00%18.49M15.20%20.12M21.85%19.58M14.97%65.98M5.30%16.37M9.48%16.07M21.10%17.47M
-General and administrative expense 1.12%19.8M13.60%74.95M2.41%16.77M15.00%18.49M15.20%20.12M21.85%19.58M14.97%65.98M5.30%16.37M9.48%16.07M21.10%17.47M
Research and development costs -0.51%82.4M33.96%330.02M15.19%77.5M21.81%81.49M45.76%88.2M60.31%82.83M42.69%246.36M29.61%67.28M48.75%66.9M34.03%60.51M
Operating profit 9.77%-92.2M-22.02%-379.42M-13.03%-94.26M9.50%-74.78M-39.42%-108.2M-51.79%-102.18M-36.98%-310.95M-24.68%-83.4M-40.07%-82.63M-32.16%-77.61M
Net non-operating interest income expense 28.96%8.95M253.35%31.05M61.95%8.7M357.97%7.85M652.14%7.56M897.27%6.94M958.55%8.79M1,911.99%5.37M991.08%1.71M458.33%1.01M
Non-operating interest income 28.96%8.95M253.35%31.05M61.95%8.7M357.97%7.85M652.14%7.56M897.27%6.94M958.55%8.79M1,911.99%5.37M991.08%1.71M458.33%1.01M
Other net income (expense) 85.70%1.86M-45.06%6.4M-80.34%2.07M136.80%1.2M1,274.73%2.14M-78.14%1M108.47%11.66M1,358.37%10.52M-62.75%-3.26M99.87%-182K
Special income (charges) 82.65%1.83M-45.00%6.42M-80.40%2.07M136.79%1.2M1,176.00%2.15M-78.17%1M108.48%11.68M1,361.24%10.54M-63.10%-3.26M99.85%-200K
-Less：Restructuring and merger&acquisition -82.65%-1.83M45.00%-6.42M80.40%-2.07M-136.79%-1.2M-1,176.00%-2.15M78.17%-1M-179.48%-11.68M-1,361.24%-10.54M63.10%3.26M-98.31%200K
Other non- operating income (expenses) 933.33%25K10.00%-18K104.17%1K-128.57%-2K-177.78%-14K85.71%-3K-400.00%-20K---24K--7K1,700.00%18K
Income before tax 13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M-38.37%-84.17M60.30%-76.79M
Income tax
Net income 13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M-38.37%-84.17M60.30%-76.79M
Net income continuous Operations 13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M-38.37%-84.17M60.30%-76.79M
Minority interest income
Net income attributable to the parent company 13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M-38.37%-84.17M60.30%-76.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.64%-81.39M-17.72%-341.97M-23.69%-83.5M21.91%-65.73M-28.28%-98.51M-51.89%-94.24M20.16%-290.51M-0.07%-67.5M-38.37%-84.17M60.30%-76.79M
Basic earnings per share 20.51%-0.62-7.72%-2.79-19.64%-0.6728.95%-0.54-14.08%-0.81-36.84%-0.7832.20%-2.599.68%-0.56-15.15%-0.7666.19%-0.71
Diluted earnings per share 20.51%-0.62-7.72%-2.79-19.64%-0.6728.95%-0.54-14.08%-0.81-36.84%-0.7832.20%-2.599.68%-0.56-15.15%-0.7666.19%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg